While they are keen to reassure us that they do not consider gene doping to be a current issue, it seems that the British Horseracing Authority has significant concerns to the tune of £1m which it has added to an international pot to ensure that the practice does not find its way into the sport as bonusbets.com reports.
Gene doping is basically the term used to cover the science of gene manipulation for the sole purpose of enhancing performance. Obviously breeders have been using the practices of natural selection for years and explicitly breeding their best examples of racing horses to create new thoroughbred lines that are even better, but until now actually manipulating genes in a lab is something we have not seen.
Less than a decade ago the idea was touted as future development, and now the know-how exists to make it a reality. Keen to keep the industry free from what would essentially be cheating there is an international team working on staying ahead of the potential threat. As they are keen to reinforce there is no danger right now, but if it were to find its way into the sport the consequences could be disastrous, and this is not something the industry wants and has global commitment to prevent.
The money will be used for various things including research as the Chief Regulatory Officers, Brant Dunshea explains. “Late last year we were in discussion with our laboratories, who said that we need to be part of international collaboration on gene doping to ensure that we are not globally duplicating work. Across six or seven countries, we are all working together to do various pieces of the jigsaw puzzle on gene doping. There’s no specific evidence that we’re aware of in relation to there being genetic manipulation that’s happening, but we haven’t done the research yet to be able to develop the techniques to be able to monitor it, so that’s what this research is all about.”
This initiative will offer reassurance to trainers and breeders, the majority of whom would not want to see the sport polluted in this way. David Sykes, the British Horseracing Authority’s director of equine health and welfare explained how technology could undermine the competition and create issues. “This is new technology that is unravelling all the time. None of us here think that there has probably been a previous incidence of it, but that doesn’t mean that we shouldn’t be looking forward into the next five or 10 years and at least being able to identify if it is going to occur. For example, you could send in the material which would alter the EPO [erythropoietin] receptor site, to allow an animal to produce increased levels of EPO naturally [and increase the blood’s oxygen-carrying capacity]. That could be expanded to anything else. For example, you could target muscle mass and increasing it, or at some point talk about circulatory systems, increasing blood supply or even cardiac muscle size by genetically altering the DNA sequence.”